[Idiopathic thrombocytopenic purpura in children. Therapeutic evaluation].
Twenty-two children who filled the criteria established for thrombocytopenic purpura chronic idiopathic, were reviewed for this study. The greatest incidence of the disease showed up between 10 to 14 years of age and there were no differences as to sex. Hemorrhagic manifestations were insidious, but all cases shewed petechiae, ecchymoses and epistaxes. There yere no cases of central nervous system hemorrhage or deaths. Splenectomy was practiced to 15 patients with evolution greater than 6 months. Full remission was obtained in 80% of the cases, which is one of the highest reported. Patients showing a platelet count above 100.000 x mm3 on the first postoperative day went into remission; therefore, we con
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013156:Splenectomy
D011241:Prednisone
Púrpura trombocitopénica idiopática en niños. Evaluación terapéutica.